Morning Report 23 May 23: Pfizer shares rally off the back of new weight loss pill

Tom and Ryan look to the U.S first where Wall Street remains pensive ten days out from debt ceiling default. China has banned the sale of U.S Micron Technology products citing a national security risk. Pfizer shares have rallied off the back of a new weight loss pill. Plus the team look at commodities and the AUD.  The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

There are no comments yet.

Please log in to write the first comment.